𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes

✍ Scribed by S.-M. Lee; H. Yang; D. M. Tartar; B. Gao; X. Luo; S. Q. Ye; H. Zaghouani; D. Fang

Publisher
Springer
Year
2011
Tongue
English
Weight
732 KB
Volume
54
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Diet can influence the ability of nicoti
Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study
✍ P.E. Beales; L.A. Burr; G.P. Webb; K.J. Mansfield; P. Pozzilli πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Background The non-obese diabetic (NOD) mouse is a widely used model of Type 1 diabetes mellitus (Type 1 DM), which displays many of the characteristics of the disease found in humans. Nicotinamide (NA) is currently being tested in large-scale, multi-centre human trials for the prevention of Type 1

Heparanase prevents the development of t
Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production
✍ Menachem Bitan; Lola Weiss; Michael Zeira; Shoshana Reich; Orit Pappo; Israel Vl πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 216 KB

## Abstract ## Background Heparanase is an endo‐β‐D‐glucuronidase that cleaves heparan sulfate saccharide chains. The enzyme promotes cell adhesion, migration and invasion, and was shown to play a significant role in cancer metastasis and angiogenesis. ## Methods The present study focuses on the

Preventive effect of a new immunosuppres
Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice
✍ J. Miyagawa; K. Yamamoto; T. Hanafusa; N. Itoh; C. Nakagawa; A. Otsuka; H. Katsu πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 296 KB

We investigated the effect of an immunosuppressant FK-506 on histological change of islets, the onset of diabetes, and the change of spleen cell subsets in female non-obese diabetic mice. Mice administered intraperitoneally with FK-506 from 5 to 20weeks of age showed marked suppression of mononuclea